🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Randomized study of PRT054021 40 mg and 15 mg bid vs. enoxaparin 30 mg q12h...
Status
Completed
Location
Montreal General Hospital
Start Date
2006-05
Trial ID
NCT00375609
Treatments Being Tested
The aim of the study is to evaluate efficacy and safety of venous thromboem...
Status
Completed
Location
Clinical Hospital no.1 of the President's Administration of Russian Federation
Start Date
2017-02-01
Trial ID
NCT03044574
A phase III, randomised, parallel-group, double-blind, active controlled st...
Status
Completed
Location
1160.25.06108 Boehringer Ingelheim Investigational Site
Start Date
2004-11
Trial ID
NCT00168805
Treatments Being Tested
The primary objective is to test the hypothesis that enoxaparin efficacy is...
Status
Terminated
Location
Military Institute of Medicine
Start Date
2015-10-01
Trial ID
NCT04558892
Treatments Being Tested
The study will evaluate the incidence of major bleeding (including clinical...
Status
Completed
Location
University of Southern California Keck School of Medicine
Start Date
2015-04-28
Trial ID
NCT02366871
Treatments Being Tested
Implantable venous access port infections are mainly due to coagulase negat...
Status
Unknown
Location
CHU Clermont-Ferrand
Start Date
2015-03
Trial ID
NCT02411331
Treatments Being Tested
Thromboprophylaxis for pancreatic surgery can be commenced either preoperat...
Status
Recruiting
Location
Sunnybrook Health Sciences Centre
Start Date
2022-08-17
Trial ID
NCT05245877
Treatments Being Tested
Sepsis is a leading cause of morbidity and mortality in intensive care unit...
Status
Completed
Location
Ghada El Adly
Start Date
2022-02-01
Trial ID
NCT05293132
Treatments Being Tested
The purpose of this study is to compare the use of oral apixaban to subcuta...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07716332
Treatments Being Tested
The primary objective of the trial is to demonstrate non-inferiority of 220...
Status
Completed
Location
1160.64.01005 Boehringer Ingelheim Investigational Site
Start Date
2008-03
Trial ID
NCT00657150
Treatments Being Tested